MURFREESBORO, TN / ACCESSWIRE / November 5, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its fourth quarter dividend of $0.90 per common share on January 29, 2025 to stockholders of record as of December 31, 2024. About NHI Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments.
MURFREESBORO, TN / ACCESSWIRE / November 5, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and nine months ended September 30, 2024. Financial Results and Recent Events Net income attributable to common stockholders per diluted common share for the three months ended September 30, 2024 was $0.65 compared to $0.68 during the same period in the prior year.
The heavy selling pressure might have exhausted for National Health Investors (NHI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
MURFREESBORO, TN / ACCESSWIRE / October 10, 2024 / National Health Investors, Inc. (NYSE:NHI) has issued an investor update which can be found at: NHI | Presentations and Webcasts (nhireit.com) Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
MURFREESBORO, TN / ACCESSWIRE / October 3, 2024 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the third quarter ended September 30, 2024. NHI plans to issue its earnings release after the market closes on Tuesday, November 5, 2024, and will host a conference call on the following day, Wednesday, November 6, 2024, at 11:00 a.m.
National Health Investors has shown strong portfolio improvements, driven by increased senior housing occupancy and a recovering industry landscape. NHI's financial performance is robust, with double-digit FFO growth in Q2 and significant NOI expansion. The stock currently yields 4.3% with a well-covered dividend and a healthy balance sheet, but a P/FFO of 18.2 suggests it's fully valued at present.
Does National Health Investors (NHI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Does National Health Investors (NHI) have what it takes to be a top stock pick for momentum investors? Let's find out.
MURFREESBORO, TN / ACCESSWIRE / August 14, 2024 / National Health Investors, Inc. (NYSE:NHI) (the "Company") announced today the pricing of an underwritten public offering of 2,400,000 shares of its common stock at a public offering price of $71.25 per share, all of which will be offered on a forward basis through the forward purchasers (as defined below) or their respective affiliates in connection with the forward sale agreements described below. The underwriters were also granted a 30-day option to purchase up to an additional 360,000 shares of the Company's common stock from the forward purchasers.
MURFREESBORO, TN / ACCESSWIRE / August 14, 2024 / National Health Investors, Inc. (NYSE:NHI) (the "Company") announced today that it has commenced an underwritten public offering of 2,000,000 shares of its common stock, all of which will be offered on a forward basis through the forward purchasers (as defined below) or their respective affiliates in connection with the forward sale agreements described below. The underwriters of the offering also expect to be granted a 30-day option to purchase up to an additional 300,000 shares of the Company's common stock from the forward purchasers.
National Health Investors, Inc. (NYSE:NHI ) Q2 2024 Earnings Conference Call August 7, 2024 11:00 AM ET Company Participants Dana Hambly - Director of IR Eric Mendelsohn - President and CEO Kevin Pascoe - Chief Investment Officer John Spaid - Chief Financial Officer Conference Call Participants Robin Haneland - BMO Capital Markets Rich Anderson - Wedbush John Kilichowski - Wells Fargo Austin Wurschmidt - KeyBanc Capital Markets Operator Good morning, everyone, and welcome to the National Health Investors Second Quarter 2024 Earnings Webcast and Conference Call. At this time, all participants have been placed on a listen-only mode, and we will open the floor for your questions and comments after the presentation.
The headline numbers for National Health Investors (NHI) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.